Pseudomonas aeruginosa : targeting cell-wall metabolism for new antibacterial discovery and development

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant to most antibiotics. With therapeutic options against P. aeruginosa dwindling, and the lack of new antibiotics in advanced developmental stages, strategies for preserving the effectiveness of current antibioti...

Full description

Bibliographic Details
Published in:Future medicinal chemistry, Vol. 8, No. 9 (2016), p. 975-92
Main Author: Lamers, Ryan P (Author)
Other Involved Persons: Burrows, Lori L
Format: electronic Article
Item Description:Date Completed 09.08.2017
Date Revised 15.12.2017
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
QR Code: Show QR Code